NEWS: 公告在東京證券交易所JASDAQ標準市場新上市



Acute Ischemic Stroke Diagnosis Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 850095
出版日期 內容資訊 英文 111 Pages
商品交期: 2-3個工作天內
急性缺血性中風診斷的全球市場:成長率、趨勢、預測 Acute Ischemic Stroke Diagnosis Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年08月01日內容資訊: 英文 111 Pages


第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長促進因素
  • 阻礙市場成長要素
  • 波特的五力分析

第5章 市場區隔

  • 診斷各類型
    • CT
    • MRI
    • 頸動脈超音波
    • 腦血管攝影
    • 心電圖檢驗
    • 心臟超音波檢驗
    • 其他診斷類型
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abbott Laboratories
    • Covidien PLC
    • GE Healthcare
    • 日立
    • Johnson and Johnson
    • Penumbra, Inc.
    • Philips Healthcare
    • Siemens Healthcare
    • Stryker Corporation (Concentric Medical, Inc.)

第7章 市場機會及未來趨勢


Product Code: 66058

The rising prevalence of acute ischemic stroke cases is driving the global demand for both diagnostic and surgical procedures in acute stroke treatment. Technological advancements in surgical procedures, along with a rising ageing population, increased demand for minimally invasive procedures, and growth in health care spending is the other major factors driving the growth of the global acute ischemic stroke diagnosis and treatment market. Excessive usage of medication for the treatment of ischemic stroke and the high cost of surgical procedures are hindering the growth of the market.

Key Market Trends

The Computerized Tomography (CT) Segment Led the Global Market in 2018

Imaging studies are used in ischemic diagnosis for the detection of haemorrhage in the acute stroke patient, in order to assess the degree of brain injury and to identify the vascular lesion responsible for the ischemic deficit.

Some advanced CT and MRI technologies are able to distinguish between brain tissue that is irreversibly infarcted and that which is potentially salvageable, thereby allowing better selection of patients likely to benefit from therapy.

In 2018, the leading diagnostic segment was computed tomography. The highest share of CT techniques is attributable to widespread access and speed of acquisition. In the hyperacute phase, a non-contrast CT (NCCT) scan is usually ordered to exclude or confirm haemorrhage; it is highly sensitive for this indication.

North America Holds the Largest Market Share

By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle-East & Africa (MEA), and South America. North America is the largest market for acute ischemic stroke diagnosis devices and is estimated to continue its stronghold of the market, owing to favourable government initiatives, technological innovations, and increasing demand for ischemic stroke products.

Asia-Pacific is expected to be the fastest-growing market for acute ischemic stroke diagnosis, owing to the increasing incidences of ischemic stroke cases in the region. Manufacturers are expanding their operations in the Asia-Pacific region, as these regions hold immense potential for market growth.

Competitive Landscape

The leading vendors of acute ischemic stroke diagnosis products are expanding their operations in Asian countries (India, China, Japan, and South Korea), as these economies hold immense potential for acute ischemic stroke diagnosis and treatment products. Major players operating in the global acute ischemic stroke diagnosis and treatment market include Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd, GE Healthcare, Hitachi Ltd, Nihon, Kohden Corporation, Canon Medical Systems Corporation and Koninklijke Philips NV are among Others

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support



  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 The Rising Number of Acute Stroke Patients
    • 4.2.2 Technological Innovations in Diagnostic and Surgical Devices
  • 4.3 Market Restraints
    • 4.3.1 Alternative Treatments and High Costs
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 Diagnostic Type
    • 5.1.1 Computed Tomography
    • 5.1.2 Magnetic Resonance Imaging
    • 5.1.3 Carotid Ultrasound
    • 5.1.4 Cerebral Angiography
    • 5.1.5 Electrocardiography
    • 5.1.6 Echocardiography
    • 5.1.7 Other Diagnostic Types
  • 5.2 Geography
    • 5.2.1 North America
      • United States
      • Canada
      • Mexico
    • 5.2.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.2.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.2.4 Middle East & Africa
      • GCC
      • South Africa
      • Rest of Middle East & Africa
    • 5.2.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Fujifilm Holdings Corporation
    • 6.1.2 Samsung Electronics Co. Ltd
    • 6.1.3 GE Healthcare
    • 6.1.4 Hitachi Ltd
    • 6.1.5 Nihon Kohden Corporation
    • 6.1.6 Canon Medical Systems Corporation
    • 6.1.7 Koninklijke Philips NV
    • 6.1.8 Siemens Healthineers AG
    • 6.1.9 Mindray Medical International Limited
    • 6.1.10 Nanavati Super Speciality Hospital
    • 6.1.11 Mayo Clinic
    • 6.1.12 Cleveland Clinic
    • 6.1.13 Global Diagnostics (Integral Diagnostics Group)
    • 6.1.14 Memorial Health System (Memorial Medical Center)